One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine (Plaquenil), a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. Plaquenil imprint 1 gg 260 5 year plaquenil protocol Hydroxychloroquine Plaquenil® is a 4-amino-quinoline antimalarial medication that is widely used to treat systemic lupus erythematosus SLE, rheumatoid arthritis, and related inflammatory and dermatological conditions. It is a hydroxylated version of chloroquine, with a similar mechanism of action. However, following an identical dose of. Given the efficacy of observed even in this small clinical trial, it seems likely that hydroxychloroquine will be widely used in the treatment of COVID-19 caused by SARS-CoV-2. Whether azithromycin should be included remains to be determined. Either way, the use of hydroxychloroquine, a widely available and inexpensive drug, is a welcome. Many systemic medications may cause retinal toxicity. One such commonly used medication for dermatologic and rheumatologic inflammatory conditions is hydroxychloroquine Plaquenil, a chloroquine derivative. It is used to treat many diseases including malaria, rheumatoid arthritis and systemic lupus erythematosus. It is imperative that patients and physicians are aware of and watch for this drug’s ocular side effects. Retinal toxicity from hydroxychloroquine is rare, but even if the medication is discontinued, vision loss may be irreversible and may continue to progress. Hydroxychloroquine widely use Hydroxychloroquine, the drug that could stop COVID-19 - archyde, Hydroxychloroquine reduces viral load in COVID-19 patients Aralen medicine On March 18, an article in the scientific journal Cell Discovery showed that the inexpensive and widely available drug hydroxychloroquine HCQ can stop the in vitro infection of cultured monkey kidney cells by SARS-CoV-2. This drug is already being widely used to treat autoimmune disorders like lupus and rheumatoid arthritis. COVID-19 Diagnostics, Hydroxychloroquine, Plasma, Short.. Hydroxychloroquine-Induced Retinal Toxicity - American.. COVID-19 Trump says anti-malaria drug hydroxychloroquine.. S ir, Hydroxychloroquine is widely used in the treatment of rheumatoid arthritis and systemic lupus erythematosus, with very few reported side‐effects. We report the case of a 65‐yr‐old woman who developed Stevens–Johnson syndrome 2 weeks after commencing treatment with hydroxychloroquine. Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more. Although hydroxychloroquine is widely used in Britain, North America and Australia, chloroquine may be more common in Europe, South America and Asia. Hydroxychloroquine use has markedly increased because it has become a first-line drug for some forms of arthritis and lupus erythematosus.